Safety and efficacy of controlled-release mesalamine for maintenance of remission in ulcerative colitis. Pentasa UC Maintenance Study Group (Q34723231)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	Safety and efficacy of controlled-release mesalamine for maintenance of remission in ulcerative colitis. Pentasa UC Maintenance Study Group	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7851193

retrieved

4 August 2017

title

Safety and efficacy of controlled-release mesalamine for maintenance of remission in ulcerative colitis. Pentasa UC Maintenance Study Group (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7851193

retrieved

4 August 2017

author name string

Miner P

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7851193

retrieved

4 August 2017

Hanauer S

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7851193

retrieved

4 August 2017

Robinson M

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7851193

retrieved

4 August 2017

Schwartz J

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7851193

retrieved

4 August 2017

Arora S

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7851193

retrieved

4 August 2017

publication date

1 February 1995

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7851193

retrieved

4 August 2017

published in

Digestive Diseases and Sciences

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7851193

retrieved

4 August 2017

volume

40

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7851193

retrieved

4 August 2017

issue

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7851193

retrieved

4 August 2017

page(s)

296-304

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7851193

retrieved

4 August 2017

cites work

Sulfasalazine. Pharmacology, clinical use, toxicity, and related new drug development

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FBF02065413

retrieved

21 January 2018

Advances in drug therapy for inflammatory bowel disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FBF02065413

retrieved

21 January 2018

An experiment to determine the active therapeutic moiety of sulphasalazine

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7851193

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adverse reactions during salicylazosulfapyridine therapy and the relation with drug metabolism and acetylator phenotype

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7851193

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of delayed-release 5-aminosalicylic acid (mesalazine) and sulfasalazine as maintenance treatment for patients with ulcerative colitis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7851193

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Controlled trial comparing olsalazine and sulphasalazine for the maintenance treatment of ulcerative colitis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7851193

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nephrotoxic lesions from 5-aminosalicylic Acid.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7851193

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Male infertility due to sulphasalazine

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7851193

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hypersensitivity with hepatotoxicity to mesalazine after hypersensitivity to sulfasalazine

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7851193

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The influence of metabolic variation on analgesic nephrotoxicity. Experiments with the Gunn rat.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7851193

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intermittent therapy with high-dose 5-aminosalicylic acid enemas for maintaining remission in ulcerative proctosigmoiditis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7851193

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CONTROLLED TRIAL OF SULPHASALAZINE IN THE TREATMENT OF ULCERATIVE COLITIS.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7851193

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Optimum dose of sulphasalazine for maintenance treatment in ulcerative colitis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7851193

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Absorption, metabolism, and excretion of salicylazosulfapyridine in man

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7851193

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reversible Toxic Effect of Salicylazosulf Apyridine on Semen Quality

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7851193

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relapse-preventing effect and safety of sulfasalazine and olsalazine in patients with ulcerative colitis in remission: a prospective, double-blind, randomized multicenter study. The Ulcerative Colitis Multicenter Study Group

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7851193

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

5-Aminosalicylic acid enemas: effective agent in maintaining remission in left-sided ulcerative colitis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7851193

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Red cell abnormalities associated with sulphasalazine maintenance therapy for ulcerative colitis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7851193

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The metabolism of salicylazosulphapyridine in ulcerative colitis. I. The relationship between metabolites and the response to treatment in inpatients

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7851193

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Incidence of sulphasalazine-induced male infertility

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7851193

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Male infertility due to sulphasalazine

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7851193

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Azodisal sodium in the treatment of ulcerative colitis. A study of tolerance and relapse-prevention properties

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7851193

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of corticosteroid and sulphasalazine therapy in ulcerative colitis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7851193

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7851193

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mesalamine capsules for treatment of active ulcerative colitis: results of a controlled trial. Pentasa Study Group.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7851193

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sulfasalazine: I. An historical perspective

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7851193

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Male infertility due to sulphasalazine

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7851193

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sulphasalazine and salicylazosulphadimidine in ulcerative colitis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7851193

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Azulfidine-induced oligospermia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7851193

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A controlled therapeutic trial of long-term maintenance treatment of ulcerative colitis with sulphazalazine (Salazopyrin).

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7851193

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic Efficacy of Sulfasalazine and Its Metabolites in Patients with Ulcerative Colitis and Crohn's Disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7851193

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

5-Aminosalicylic acid in the treatment of Crohn's disease. A 16-week double-blind, placebo-controlled, multicentre study with Pentasa

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7851193

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7851193

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Male infertility due to sulphasalazine

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7851193

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical Pharmacokinetics of Sulphasalazine

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7851193

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Is Plasma Level Monitoring of Sulfasalazine Indicated in the Treatment of Crohnʼs Disease or Ulcerative Colitis?

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7851193

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Exacerbation of ulcerative colitis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7851193

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/BF02065413

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7851193

retrieved

4 August 2017

Dimensions Publication ID

1050449769

0 references

PubMed publication ID

7851193

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7851193

retrieved

4 August 2017

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34723231&oldid=2196980694"